Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 7, 2026Neurología (English Edition)Open Access

Barriers to access to anti-CGRP monoclonal antibodies in Spain: survey of neurologists, hospital pharmacists, and patients

View Full Paper
Ask AI
Bookmark
Share

Authors

PIPablo IrimiaPRPilar Díaz RuizICIsabel Colomina

Discussion

Loading...

Member takes

Overview

Cross-sectional study identifies barriers to access and suggests improvements for referral and specialist access.

Key Points

  • To identify barriers to access to anti-CGRP monoclonal antibodies for migraine prophylaxis in Spain.
  • Cross-sectional study conducted with online surveys of neurologists, hospital pharmacists, and patients.
  • Descriptive statistics were used to analyse the survey data.
  • 55.1% of neurologists and 67.4% of hospital pharmacists reported case-by-case TPS criteria adherence.
  • 62.8% of neurologists disagreed with some TPS criteria, indicating a call for revision.
  • 32.9% of patients experienced difficulty accessing a migraine specialist.

Cite This Study

Irimia et al. (2026) studied this question.

synapsesocial.com/papers/69fbe382164b5133a91a2b6bhttps://doi.org/10.1016/j.nrleng.2026.502081
View Full Paper
Ask AI
Bookmark
Share